Cardiff Oncology (CRDF) P/E (2012 - 2026)
Cardiff Oncology (CRDF) P/E from Apr 2, 2012 to Jul 21, 2026. The TTM Cardiff Oncology (CRDF) P/E is -1.27. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cardiff Oncology (CRDF)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.27 | -69.14% |
| 2025 | -4.10 | -14.68% |
| 2024 | -4.81 | +196.69% |
| 2023 | -1.62 | +6.22% |
| 2022 | -1.53 | -82.01% |
| 2021 | -8.48 | -44.40% |
| 2020 | -15.26 | +591.24% |
| 2019 | -2.21 | -32.05% |
| 2018 | -3.25 | -14.37% |
| 2017 | -3.79 | -81.02% |
| 2016 | -19.99 | -58.68% |
| 2015 | -48.37 | +42.18% |
| 2014 | -34.02 | -31.42% |
| 2013 | -49.61 | -4.47% |
| 2012 | -51.93 | N/A |
Comparison Cardiff Oncology (CRDF) P/E with competitors
Cardiff Oncology (CRDF) P/E is -1.27.